Figure 5.

The relationship of TET2, ANRIL, and patient survival time in gastric cancer. (a) Patients have longer survival time with high TET2 expression or low ANRIL expression (there are 192 patients analyzed, and the patient numbers classified with low or high expression are indicated), (b) the mRNA expression levels of TET2 and ANRIL are negatively correlated, (c) the mRNA expression levels of p21 and ANRIL are positively correlated, (d) the mRNA expression levels of cIAP1 and ANRIL are positively correlated, (e) the mRNA expression levels of uPA and ANRIL are positively correlated, and (f) the mRNA expression levels of MMP2 and ANRIL are positively correlated. (A color version of this figure is available in the online journal.)

ANRIL: CDKN2B-AS; TET2: Tet Methylcytosine Dioxygenase 2.